Thursday, May 10, 2007

Bioabsorbable Therapeutics Scores Series B

Menlo Park-based Bioabsorable Therapeutics announced today that the firm has raised $9M in a Series B round. The investment came from Finistere Ventures and ITX International Equity. The firm is developing a biodegradable polymer used for coronary stents. The funding will go towards human clinical trials. More information »